Skip to content
Search

Latest Stories

NHS of tomorrow must capitalise on community pharmacy’s potential – CPE

NHS 10-Year Plan
Pharmacy (gettyimages)

'Community pharmacy can effectively support the government’s three shifts if funding for the sector is stabilised'

Community Pharmacy England (CPE) has submitted proposals for NHS 10-Year Plan, highlighting economic stabilisation of the sector, making Pharmacy First a walk-in service, and regulatory changes to enable pharmacists to better deal with medicines shortages as “quick and crucial ways” to improve the current situation.

In October, the health secretary launched a national conversation, seeking input and ideas to shape the future of the health service via the change.nhs.uk portal. Healthcare organisations were also invited to make formal submissions.


In their submission, the CPE emphasised the need for the NHS to leverage pharmacy's potential to identify “people with undiagnosed conditions and support behaviour changes to reduce the future likelihood of ill health.”

The organisation also underscored the importance of addressing the sector’s current funding gap, noting that “community pharmacy is lagging behind funding uplifts given to the rest of the NHS.”

In its response, the CPE states: “Community pharmacies can effectively support the Government’s three shifts, enhancing access to care for all patients, including those less well served by other parts of the NHS, supporting work to prevent ill health and providing improved outcomes for individuals and the NHS, but in order to achieve this, it is necessary for the NHS funding for the sector to be stabilised.”

CPE chief executive Janet Morrison emphasised the critical timing of the NHS plan, noting its significance for community pharmacies, which are in “an ever-more precarious position.”

She said: “Our overarching aim is to see increased commissioning of pharmacy services for the benefit of patients, the public and the wider NHS.

“But this cannot happen without first resolving the critical need for investment in community pharmacies, as well as a more supportive regulatory structure and better collaboration across the whole health service.”

Furthermore, Morrison noted that the NHS of tomorrow must capitalise on “community pharmacy’s USP – easily accessible healthcare advice and treatment close to where people live, shop and work – to help meet the government’s ambition to shift the focus of healthcare towards prevention.”

Community Pharmacy England's key proposals include: putting community pharmacies at the centre of primary care delivery, investing in the long-term stability of the sector, preventing closures, ensuring a supportive regulatory framework, expanding commissioned services, and promoting collaboration across primary care.

Sector facing significant funding pressures

The organisation also pointed out that the current funding model is “unsustainable and risks undermining efforts to embed Pharmacy First while putting core dispensing and supply services at risk.”

Community pharmacy funding has reduced from £2.8bn in 2015/16 to £2.592bn in 2023/24.

“The reduction in funding is causing pharmacies to close, totalling over 1,400 since the funding cut took effect,” it said.

The CPE’s Pharmacy Pressures Survey 2024 revealed that the trend in pharmacy closures is accelerating with an average of 10 pharmacies closing per week in the first four months of 2024, nearly 50 per cent higher than the same period in 2023.

One in six respondents stated that they are unlikely to remain open in a year and 64 per cent of pharmacy premises reported operating at a loss.

Over half of pharmacy staff surveyed reported that patients are being negatively affected as a result of these pressures.

CPE also proposes expanding Pharmacy First, vaccination programs, and women’s health services to shift more care from hospitals to community settings.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less